BHP Billiton Limited vs Eli Lilly And Co — how do they compare? BHP Billiton Limited trades at $83.14 (market cap $205.61B), while Eli Lilly And Co trades at $1,155 (market cap $1.03T). The key difference: Eli Lilly And Co is far larger — about 5× BHP Billiton Limited's market cap, and BHP Billiton Limited pays the higher dividend (3.15%). Which is the better fit depends on your goals.
| BHP | LLY | |
|---|---|---|
Market Cap | $205.61B | $1.03T |
Sector | Basic Materials | Health |
52-Week High | $93.15 | $1.24K |
52-Week Low | $50.65 | $625.65 |
Enterprise Value | $219.82B | $1.07T |
Dividend Yield | 3.15% | 0.6% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,185.08, down slightly (-0.29%) on the day, with a strong bullish technical signal from moving averages. The company demonstrates exceptional fundamental strength, with revenue surging to $65.18B in 2025 and a net income margin of 34.99%. Recent earnings have consistently beaten expectations, and analyst sentiment is overwhelmingly positive, with a consensus price target of $1,360.
The outlook for LLY remains robust, driven by its dominant position in the high-growth weight loss and Alzheimer's drug markets. Key opportunities include continued revenue expansion and pipeline advancements. Primary risks involve intensifying competition, particularly from Novo Nordisk's obesity pill, and the stock's premium valuation multiples, which demand sustained high growth to justify.
Trailing returns across standard periods
Latest headlines on both assets
BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.
Read more on BHP →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →